Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sheng

Showing results (231-240 of 669) with videos related to

Pageof 67
Sort By:
Frontiers in Pharmacology|April 18, 2022
An Ayurgenomics Approach: Prakriti-Based Drug Discovery and Development for Personalized CareZoufang Huang, Vivek P Chavda, Rajashri Bezbaruah, et al.
Bioorganic & Medicinal Chemistry Letters|October 17, 2012
Design, synthesis and biological evaluation of N-arylphenyl-2,2-dichloroacetamide analogues as anti-cancer agentsTianwen Li, Yongchong Yang, Changmei Cheng, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 12, 2023
Silver-dendrimer nanocomposite as emerging therapeutics in anti-bacteria and beyondXiaoling Fu, Urushi Rehman, Liuya Wei, et al.
Cancer Genetics|December 11, 2025
Genetic modulation of ABCB1: Sunvozertinib reverses ABCB1-mediated multidrug resistance in cancer cellsLu-Qi Cao, Yuhao Xie, Xuanyu Chen, et al.
European Journal of Medicinal Chemistry|January 24, 2025
Recent advances in small molecule design strategies against hepatic fibrosisHeming Chen, Wei Su, Tingting Li, et al.
Molecular Cancer|February 13, 2019
circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancerHailin Tang, Xiaojia Huang, Jin Wang, et al.
Medcomm|May 25, 2023
Understanding and targeting resistance mechanisms in cancerZi-Ning Lei, Qin Tian, Qiu-Xu Teng, et al.
Carcinogenesis|December 3, 2013
Cancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancerZi Liu, Liang Ma, Zhe-Sheng Wen, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 11, 2023
Antimicrobial peptides for combating drug-resistant bacterial infectionsJiaqi Xuan, Weiguo Feng, Jiaye Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 27, 2026
Cascade-Responsive MXene@Cu-MOF Heterostructure Integrates Antioxidant Activity, Infection Control, and Vascularization for Tracheal RepairLiang Guo, Yingran Shen, Jiaoyu Yi, et al.
Pageof 67

Showing results (231-240 of 669) with videos related to

Sort By:
Pageof 67
Frontiers in Pharmacology|April 18, 2022
An Ayurgenomics Approach: Prakriti-Based Drug Discovery and Development for Personalized CareZoufang Huang, Vivek P Chavda, Rajashri Bezbaruah, et al.
Bioorganic & Medicinal Chemistry Letters|October 17, 2012
Design, synthesis and biological evaluation of N-arylphenyl-2,2-dichloroacetamide analogues as anti-cancer agentsTianwen Li, Yongchong Yang, Changmei Cheng, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 12, 2023
Silver-dendrimer nanocomposite as emerging therapeutics in anti-bacteria and beyondXiaoling Fu, Urushi Rehman, Liuya Wei, et al.
Cancer Genetics|December 11, 2025
Genetic modulation of ABCB1: Sunvozertinib reverses ABCB1-mediated multidrug resistance in cancer cellsLu-Qi Cao, Yuhao Xie, Xuanyu Chen, et al.
European Journal of Medicinal Chemistry|January 24, 2025
Recent advances in small molecule design strategies against hepatic fibrosisHeming Chen, Wei Su, Tingting Li, et al.
Molecular Cancer|February 13, 2019
circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancerHailin Tang, Xiaojia Huang, Jin Wang, et al.
Medcomm|May 25, 2023
Understanding and targeting resistance mechanisms in cancerZi-Ning Lei, Qin Tian, Qiu-Xu Teng, et al.
Carcinogenesis|December 3, 2013
Cancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancerZi Liu, Liang Ma, Zhe-Sheng Wen, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 11, 2023
Antimicrobial peptides for combating drug-resistant bacterial infectionsJiaqi Xuan, Weiguo Feng, Jiaye Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 27, 2026
Cascade-Responsive MXene@Cu-MOF Heterostructure Integrates Antioxidant Activity, Infection Control, and Vascularization for Tracheal RepairLiang Guo, Yingran Shen, Jiaoyu Yi, et al.
Pageof 67